SOLVENTUM CORPORATION Operating Income
SOLVENTUM CORPORATION (SOLV) reported Operating Income of $181.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-05
- SOLVENTUM CORPORATION operating income (loss) for the quarter ending 2026-06-30 was $181.00M, a 15.42% decline year-over-year.
- SOLVENTUM CORPORATION operating income (loss) for the quarter ending 2026-03-31 was $81.00M, a 46.71% decline year-over-year.
- SOLVENTUM CORPORATION operating income (loss) for the quarter ending 2025-12-31 was $124.00M, a 8.82% decline year-over-year.
- SOLVENTUM CORPORATION operating income (loss) for the quarter ending 2025-09-30 was $1.69B, a 514.55% increase year-over-year.
- SOLVENTUM CORPORATION operating income (loss) for fiscal 2025 was $2.18B, a 110.52% increase from fiscal 2024.
- SOLVENTUM CORPORATION operating income (loss) for fiscal 2024 was $1.04B, a 38.77% decline from fiscal 2023.
- SOLVENTUM CORPORATION operating income (loss) for fiscal 2023 was $1.69B, a 0.06% decline from fiscal 2022.
- SOLVENTUM CORPORATION operating income (loss) for fiscal 2022 was $1.69B.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $181.00M 10-Q · filed 2026-08-05 | $262.00M 10-Q · filed 2026-08-05 | $386.00M derived: sum of 3 quarters · filed 2026-08-05 | $2.08B derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $81.00M 10-Q · filed 2026-05-05 | $205.00M derived: sum of 2 quarters · filed 2026-05-05 | $1.90B derived: sum of 3 quarters · filed 2026-05-05 | $2.11B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $124.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.81B derived: sum of 2 quarters · filed 2026-02-27 | $2.03B derived: sum of 3 quarters · filed 2026-08-05 | $2.18B 10-K · filed 2026-02-27 |
| 2025-09-30 | $1.69B 10-Q · filed 2025-11-06 | $1.90B derived: sum of 2 quarters · filed 2026-08-05 | $2.06B 10-Q · filed 2025-11-06 | $2.19B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $214.00M 10-Q · filed 2026-08-05 | $367.00M 10-Q · filed 2026-08-05 | $502.00M derived: sum of 3 quarters · filed 2026-08-05 | $777.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $152.00M 10-Q · filed 2026-05-05 | $288.00M derived: sum of 2 quarters · filed 2026-05-05 | $563.00M derived: sum of 3 quarters · filed 2026-05-05 | $807.00M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $136.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $411.00M derived: sum of 2 quarters · filed 2026-02-27 | $655.00M derived: sum of 3 quarters · filed 2026-02-27 | $1.04B 10-K · filed 2026-02-27 |
| 2024-09-30 | $275.00M 10-Q · filed 2025-11-06 | $519.00M derived: sum of 2 quarters · filed 2025-11-06 | $900.00M 10-Q · filed 2025-11-06 | $1.31B derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $244.00M 10-Q · filed 2025-08-08 | $625.00M 10-Q · filed 2025-08-08 | $1.03B derived: sum of 3 quarters · filed 2026-02-27 | $1.53B derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $381.00M 10-Q · filed 2025-05-09 | $787.00M derived: sum of 2 quarters · filed 2026-02-27 | $1.29B derived: sum of 3 quarters · filed 2026-02-27 | $1.71B derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $406.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $910.00M derived: sum of 2 quarters · filed 2026-02-27 | $1.33B derived: sum of 3 quarters · filed 2026-02-27 | $1.69B 10-K · filed 2026-02-27 |
| 2023-09-30 | $504.00M 10-Q · filed 2024-11-08 | $921.00M derived: sum of 2 quarters · filed 2024-11-08 | $1.29B 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $417.00M 10-Q · filed 2024-08-09 | $782.00M 10-Q · filed 2024-08-09 | ||
| 2023-03-31 | $365.00M 10-Q · filed 2024-05-10 | |||
| 2022-12-31 | $1.69B 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |